Korea Otsuka Pharmaceutical Co., Ltd.
🇰🇷South Korea
Clinical Trials
42
Active:1
Completed:32
Trial Phases
4 Phases
Phase 1:7
Phase 2:3
Phase 3:8
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (30 trials with phase data)• Click on a phase to view related trials
Phase 4
12 (40.0%)Phase 3
8 (26.7%)Phase 1
7 (23.3%)Phase 2
3 (10.0%)Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)
Not yet recruiting
- Conditions
- Tuberculosis, Multidrug-Resistant
- Interventions
- First Posted Date
- 2024-11-05
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 222
- Registration Number
- NCT06674291
Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.
Recruiting
- Conditions
- Chronic GastritisAcute Gastritis
- First Posted Date
- 2021-09-17
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 600
- Registration Number
- NCT05048069
- Locations
- 🇰🇷
Soon Chun Hyang University Hospital Seoul, Seoul, Korea, Republic of
A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis
Phase 3
Completed
- Conditions
- Acute GastritisChronic Gastritis
- Interventions
- Drug: MCT-SR
- First Posted Date
- 2019-12-06
- Last Posted Date
- 2021-03-11
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 392
- Registration Number
- NCT04189705
- Locations
- 🇰🇷
Chung-Ang University Hospital, Seoul, Korea, Republic of
To Evaluate Pharmacokinetics and Safety of Two Different Formulation of Rebamipide in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2019-11-04
- Last Posted Date
- 2019-11-04
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT04150172
- Locations
- 🇰🇷
CHA Bundang Medical Center, CHA University, Seongnam, Gyeonggi-do, Korea, Republic of
To Evaluate Food Effect on the Pharmacokinetics of Rebamipide in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2019-11-04
- Last Posted Date
- 2019-11-04
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT04150146
- Locations
- 🇰🇷
CHA Bundang Medical Center, CHA University, Bundang, Gyeonggi-do, Korea, Republic of
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
News
No news found